We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
A new study aims to reduce hepatitis C (HCV) transmission among young adults who inject drugs. The study will equip participants with strategies to avoid situations and practices that put them at risk of contracting HCV.
The cost of the nation’s opioid crisis exceeded $1 trillion from 2001 to 2017, a new report concludes. The epidemic may cost an additional $500 billion by 2020.
The recent federal budget deal includes $6 billion in new funding to fight the opioid crisis—an amount addiction treatment experts and some lawmakers say isn’t enough, CNN reports.
Purdue Pharma, the maker of OxyContin, said it will no longer market the drug to doctors. The announcement comes in response to lawsuits that blame the company for helping to trigger the opioid crisis, CBS News reports.
Connecting people with support services such as food and housing is a key step in curbing the opioid epidemic, Surgeon General Jerome Adams said this week.
There seem to be a growing number of cases of high amounts of fluid in the lungs following administration of the opioid overdose antidote naloxone, experts said at a recent meeting of the New York Society of Addiction Medicine annual meeting.
The Food and Drug Administration is warning that the supplement known as “kratom” is an opioid and has been linked with 44 deaths, The Washington Post reports.
The increasing rate of deaths due to opioids, alcohol and suicides are part of a public health crisis described as “deaths of despair” in a new report published this week.
State and local law enforcement officials came to Capitol Hill last week to protest a Trump Administration proposal to move oversight of a drug prevention program from the Office of National Drug Control Policy to the Justice Department.
More than 150 organizations working to fight the opioid epidemic are opposing the Trump Administration’s proposed cuts to the Office of National Drug Control Policy, The Hill reports.
More than a dozen people who used fentanyl, either alone or in combination with stimulants, have suffered severe memory loss, researchers from West Virginia University report.
The Food and Drug Administration this week asked the makers of the over-the-counter anti-diarrhea drug loperamide (Imodium A-D) to change the way they package their products, in an effort to reduce abuse.
The Trump Administration renewed the order declaring the opioid crisis a public health emergency on January 22, a day before the 90-day mandate was set to expire, ABC News reports.
The Trump Administration is planning to cut more than $340 million from the budget of the White House Office of National Drug Control Policy, CBS News reports.
Nurse practitioners and physician assistants will now be eligible to prescribe and dispense the opioid addiction treatment buprenorphine from their office, Reuters reports.
Teens who use e-cigarettes are at higher risk of transitioning to smoking conventional cigarettes than their peers who don’t use vaping devices, a new report concludes.
Former Democratic Representative Patrick Kennedy, a member of President Trump’s Opioid Commission, said the Republican-led Congress has turned the group’s work into a “charade” and a “sham,” CNN reports.
Medicaid is contributing to the nation’s opioid crisis by establishing incentives that make it profitable to abuse and sell opioids, a report by Republicans on the Senate Homeland Security and Governmental Affairs Committee concludes.
This website uses cookies. We use cookies and similar technologies to give you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
